Clinical Trial Update: Chloroquinoxaline Sulfonamide in Treating Patients With Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of chloroquinoxaline sulfonamide for small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Chloroquinoxaline Sulfonamide (Chloroquinoxaline sulfonamide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED